Phase II Subthalamic Nucleus (STN) vs. Globus Pallidus (GPi) Trial
Public ClinicalTrials.gov record NCT01076452. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
CSP #468 Phase II - A Comparison of Best Medical Therapy and Deep Brain Stimulation of Subthalamic Nucleus and Globus Pallidus for the Treatment of Parkinson's Disease, Phase II
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The goal of the second phase of the study is to determine if simultaneous bilateral subthalamic nucleus stimulation or simultaneous bilateral globus pallidus stimulation is more effective in reducing symptoms of Parkinson's Disease.
Study identification
- NCT ID
- NCT01076452
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 299 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 22 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2002 (Type not available)
- Primary completion
- Oct 2008 (Actual)
- Completion
- Apr 2009 (Actual)
- Last update posted
- Jul 14, 2014
2002 – 2009
United States locations
- U.S. sites
- 14
- U.S. states
- 7
- U.S. cities
- 9
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of California at Los Angeles | Los Angeles | California | 90073 | — |
| University of California at San Francisco | San Francisco | California | 94121 | — |
| VA Medical Center, San Francisco | San Francisco | California | 94121 | — |
| VA Greater Los Angeles Healthcare System, West LA | West Los Angeles | California | 90073 | — |
| VA Medical Center, Iowa City | Iowa City | Iowa | 52246-2208 | — |
| VA Medical Center, Portland | Portland | Oregon | 97201 | — |
| Oregon Health Sciences University | Portland | Oregon | 97207 | — |
| University of Pennsylvania Hospital | Philadelphia | Pennsylvania | 19104 | — |
| Philadelphia, OPC | Philadelphia | Pennsylvania | 19106 | — |
| Baylor College of Medicine | Houston | Texas | 77030 | — |
| Michael E. DeBakey VA Medical Center (152) | Houston | Texas | 77030 | — |
| Hunter Holmes McGuire VA Medical Center | Richmond | Virginia | 23249 | — |
| Medical College of Virginia | Richmond | Virginia | 23249 | — |
| VA Puget Sound Health Care System, Seattle | Seattle | Washington | 98108 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01076452, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 14, 2014 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01076452 live on ClinicalTrials.gov.